fig1
Figure 1. Main advances in the treatment of hepatocellular carcinoma. The graphical illustration highlights some key breakthroughs in the medical treatment of advanced HCC, based on seminal studies by Llovet et al.[4], Kudo et al.[5], Finn et al.[6], and Abou-Alfa et al.[7]. HCC: Hepatocellular carcinoma; STRIDE: Single Tremelimbumab Regular Interval Durvalumab.
